Destination Wealth Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-500,245
| Closed | -$655K | – | 665 |
|
|
2019
Q1 | $655K | Sell |
500,245
-26,000
| -5% | -$34K | 0.04% | 109 |
|
|
2018
Q4 | $480K | Sell |
526,245
-75,253
| -13% | -$68.6K | 0.03% | 111 |
|
|
2018
Q3 | $1.24M | Buy |
+601,498
| New | +$1.24M | 0.07% | 96 |
|
|
2018
Q2 | – | Sell |
-601,498
| Closed | -$1.42M | – | 589 |
|
|
2018
Q1 | $1.42M | Hold |
601,498
| – | – | 0.09% | 88 |
|
|
2017
Q4 | $1.13M | Sell |
601,498
-74,295
| -11% | -$140K | 0.07% | 89 |
|
|
2017
Q3 | $1.68M | Hold |
675,793
| – | – | 0.11% | 84 |
|
|
2017
Q2 | $1.86M | Hold |
675,793
| – | – | 0.12% | 85 |
|
|
2017
Q1 | $2.04M | Hold |
675,793
| – | – | 0.14% | 77 |
|
|
2016
Q4 | $2.13M | Hold |
675,793
| – | – | 0.16% | 74 |
|
|
2016
Q3 | $2.31M | Hold |
675,793
| – | – | 0.18% | 72 |
|
|
2016
Q2 | $1.54M | Sell |
675,793
-2,172
| -0.3% | -$4.96K | 0.13% | 74 |
|
|
2016
Q1 | $2.43M | Sell |
677,965
-56,949
| -8% | -$204K | 0.23% | 58 |
|
|
2015
Q4 | $2.43M | Hold |
734,914
| – | – | 0.23% | 58 |
|
|
2015
Q3 | $1.78M | Hold |
734,914
| – | – | 0.2% | 62 |
|
|
2015
Q2 | $2.15M | Buy |
+734,914
| New | +$2.15M | 0.14% | 99 |
|
|
2015
Q1 | – | Sell |
-736,772
| Closed | -$2.22M | – | 109 |
|
|
2014
Q4 | $2.22M | Hold |
736,772
| – | – | 0.22% | 51 |
|
|
2014
Q3 | $1.87M | Hold |
736,772
| – | – | 0.2% | 54 |
|
|
2014
Q2 | $1.81M | Hold |
736,772
| – | – | 0.19% | 61 |
|
|
2014
Q1 | $1.96M | Hold |
736,772
| – | – | 0.21% | 57 |
|
|
2013
Q4 | $2.14M | Hold |
736,772
| – | – | 0.22% | 57 |
|
|
2013
Q3 | $2.26M | Hold |
736,772
| – | – | 0.26% | 53 |
|
|
2013
Q2 | $2.35M | Buy |
+736,772
| New | +$2.35M | 0.29% | 54 |
|